News TheraVet SA

Equities

ALVET

BE0974387194

Market Closed - Euronext Paris Other stock markets 09:05:04 30/04/2024 pm IST			5-day change	1st Jan Change
0.696 ^EUR	-0.57%		-10.77%	-52.00%

23/04	TheraVet SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
13/03	TheraVet SA Announces the Launch of BIOCERA-VET Equine	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TheraVet reports Full-Year 2023 Financial Results and Provides the Preparatory Documents for the General Meeting of June 6th, 2024	23/04	BU
TheraVet SA Reports Earnings Results for the Full Year Ended December 31, 2023	23/04	CI
TheraVet Reports 2023 Full Year and 2024 First Quarter Revenues	10/04	BU
BIOCERA-VET® Is Now Available for the Management of Dental and Orthopedics Conditions in Horses	13/03	BU
TheraVet SA Announces the Launch of BIOCERA-VET Equine	13/03	CI
TheraVet’s Veterinary Medicinal Product Gets Patents in Europe, Singapore, Israel	30/01	MT
Global markets live: Charles Schwab, Apple, Spirit Airlines, BP, Visa...	17/01
TheraVet SA Announces Commercial Launch of Biocera-VET in Germany	17/01	CI
Global markets live: Boeing, GSK, Hays, Shell, Eli Lilly...	09/01
TheraVet Announces Agreement with Alcyon Italia for the Distribution of BIOCERA-VET® Product Line in Italy	09/01	CI
TheraVet: positive feedback in canine osteosarcoma	04/01	CF
TheraVet launches osteosarcoma study	23/11	CF
TheraVet SA Announces Launch of Biocera-Vet Canine Osteosarcoma Study Conducted by the University of Florida	23/11	CI
TheraVet Sets Up EUR3 Million Equity-linked Funding Facility	21/11	MT
TheraVet SA announced that it expects to receive ?1 million in funding	20/11	CI
Vet Biotech TheraVet Names CFO	25/23/25	MT
TheraVet Appoints Rodolphe Lebrun as Chief Financial Officer	25/23/25	CI
TheraVet Recruits Patients for Study on Bone Substitute Use in Dog Revision Surgery	27/23/27	MT
TheraVet SA Announces Patient Recruitment Phase Successfully Completed in Biocera-Vet Fracture Revision Surgery Study in Toy Dogs	27/23/27	CI
TheraVet: financing secured until mid-2024	06/23/06	CF

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News TheraVet SA

Equities

ALVET

BE0974387194

Summary

Filters